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We have previously reported that carbamoylcholine (earbachol), a 
recognized inhibitor of somatostatin release from D-cells, can act as 
stimulant following pretreatment of cells with pertussis toxin. In the 
present studies we have observed that pertussis toxin reverses the inhibitory 
effects of carbachol on D-cell stimulated with either cAMP or 12-0- 
tetradecanoyl-phorbol 13-acetate. Furthermore, the stimulatory effects of 
carbachol on D-cells pretreated with pertussis toxin potentiated the actions 
of pentagastrin without further enhancing the release of 3H-inositol 
trisphosphate from prelabeled cells. These studies suggest that carbachol 
exerts its inhibitory effects on D-cells via pertussis toxin sensitive 
guaninine nucleotide binding proteins at a point distal to the activation of 
different signal transduction mechanisms and that the stimulatory effects of 
carbachol are mediated by mechanisms that are independent of membrane 
phosphoinositide turnover. ® 1987 Academic Press, Inc 
In previous studies we have demonstrated that carbachol, an inhibitor of 
somatostatin release from gastric D-cells under normal circumstances (I), can 
stimulate D-cells after pertussis toxin pretreatment (2). The decreased 
cellular production of adenosine 3':5'-cyclic monophosphate (cAMP) and 
enhanced turnover of membrane inositol phospholipids that accompany carbachol 
action on D-cells suggest possible mechanisms for, respectively, the 
inhibitory and stimulatory effects that were observed. We undertook these 
studies to further explore the potential mechanisms for muscarinic regulation 
of D-cells. 
MATERIALS AND METHODS 
Materials: Carbachol, dibutyryl cAMP (dbcAMP), 12-0-tetradecanoyl-phorbol 13- 
acetate (TPA), collagenase I (type I) and ethylenediaminetetra-acetic acid 
(EDTA) were purchased from Sigma Chemical (St. Louis, MO). Pentagastrin was a 
product of Peninsula Laboratories (Belmont, CA) and pertussis toxin was 
obtained from List Biological Laboratories (Campbell, CA). Earle's balanced 
salt solution and Ham's F12-Dulbecco's modified Eagle's (50:50, vol/vol) 
~ulture media were obtained from Irvine Scientific (Santa Ana, CA). (2- 
H)myo-inositol (15.8 Ci/mmol) was obtained from New England Nuclear (Boston, 
MA), and Dowex-1 resin (100-200 mesh; x 8 in the formate form) was purchased 
from Bio Rad (Richmond, CA). 
Cell Isolation and Culture: Mucosal cells were dispersed from stripped canine 
fundus by sequential exposure to collagenase (0.35 mg/ml) and EDTA (I mM), as 
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described previously (1,3). Somatostatin containing D-cells were further 
enriched by centrifugal elutriation and then cultured at a concentration 4 x 
10 cells/well on a bed of collagen in Ham's F12-Dulbecco's modified Eagle's 
medium (50:50, vol/vol) containing 10% dog serum, insulin (8 ug/ml) and 
hydrocortisone (I ug/ml) in the presence of 95% air - 5% CO 2 at 37 ° C. After 
40h of stabilization, the cells were incubated in Earle's balanced salt 
solution containing various test substances for a subsequent 2h experiment and 
somatostatin released into the media was measured by radioimmunoassay as 
described previously (4). Some experiments were performed after the cells had 
been preincubated with pertussis toxin (200 ng/ml) for 4h. 
Production of 3H-IPq: Turnover of membrane inositol phospholipids was 
assessed by measurifig the release of ~H-IP, from D-cells after first 
prelabeling for 24h at 37 ° in culture medidm (see above) containing 3H- 
inositol (20 uCi/well). During the last 15 min of incubation, lithium 
chloride was added to achieve a final concentration of 10 mM. Following the 
prelabeling period, the cells were further incubated for 5 min in I ml of 
Earle's balanced salt solution containing various test substances. The 
incubation~ were terminated by the addition of 3 ml of chloroform:methanol 
(1:2) and jH-IP~ was separated by Dowex-resin chromatography using the method 
of Fisher and B~rtus (5). The fractions denoted as containing IP 3 may consist 
of a mixture of the 1,4,5 and 1,3,4 isomers. 
RESULTS 
As depicted in Fig. I, carbachol inhibited the increase in somatostatin 
release induced by dbcAMP and TPA. Increases in cytosolic 3H-IP 3 content were 
always noted in the presence of carbachol although dbcAMP and TPA by 
themselves had no effect. These changes in cytosolic 3H-IP 3 content induced 
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Fig. I. Effects of Dertussis toxin (200 ng/ml) pretreatment on inhibition of 
dbcAMP (I0-9M) - and TPA (10-7M)-induced somatostatin release by 
carbachol (Carb, IO-4M) and on carbachol-induced release of 3H-IP 2 
from D-cells. Data are presented as means ± SE from 4 separate d6g 
preparations and were analyzed using Student's t-tests for paired 
samples. *P < 0.01 vs control (c), **P < O.01 vs dbcAMP or TPA alone. 
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Fig. 2. Effects of pertussis toxin (200 ng/ml) pretreatment on inhibition of 
pentagastr~n (PG, 10-7M)-induced somatostatin release by carbachol 
(Carb, IO-~M) and on carbachol and pentagastrin-induced release of 3H- 
IP 3 from D-cells. Data are presented as means ± SE from 4 separate 
dog preparations and were analyzed using Student's t-tests for paired 
samples. *P < 0.01 vs control (C), **P < 0.01 vs PG alone. 
by carbachol were unaltered after pre-incubation of D-cells in pertussis 
toxin, however, such treatment converted the inhibitory effect of the 
muscarinic agonist to one in which the stimulatory actions of TPA and dbcAMP 
were potentiated. In contrast to TPA and dbcAMP, pentagastrin, like 
enhanced 3H-IP 3 production in D-cells (Fig. 2). Carbachol carbachol, 
inhibited the stimulatory effect of pentagastrin on somatostatin release 
altering 3H-IP 3 production. However, after pretreatment without of D-cells 
with pertussis toxin, carbachol potentiated the stimulatory effect of 
pentagastrin on somatostatin release, again without changing the level of 3H- 
IP 3 production. 
DISCUSSION 
In previous studies we have observed that inhibition of basal as well as 
forskolin-stimulated somatostatin release from gastric D-cells is paralleled 
by decreases in cellular cAMP content, and that these changes could be 
prevented by pretreatment with pertussis toxin (2). Since pertussis toxin is 
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known to inactivate the inhibitory guanine nucleotide binding proteins 
regulating adenylate cyclase activity by promoting their ADP-ribosylation (6), 
our data suggest that muscarinic agonists exert their inhibitory effects on D- 
cells, at least in part, by attenuation of cellular cAMP generation. The 
present studies indicate, however, that the inhibitory action of muscarinic 
agonists may occur at a point distal to the production of cAMP since the 
stimulation of somatostatin release by dbcAMP itself could be inhibited by 
carbachol in a fashion preventable with pertussis toxin. Moreover, we 
observed that stimulation of somatostatin release by both TPA and 
pentagastrin, processes which we have previously demonstrated to be mediated 
via protein kinase C activation (7), could also be inhibited by carbachol via 
a pertussis toxin sensitive pathway. Taken together, these data suggest that 
muscarinic inhibitory actions on D-cells may be mediated by inhibitory guanine 
nucleotide regulatory proteins that exert their effects at multiple sites or 
at some single site at which various signal transduction pathways converge to 
stimulate D-cells. The mechanisms for such an activity is unknown but may 
possibly involve such basic processes as phosphoprotein dephosphorylation or 
ion channel gating, both of which are known guanine nucleotide binding protein 
dependent actions of cholinergic agonists in other systems (8,9). 
We have confirmed our original observations that after pretreatment with 
pertussis toxin D-cell somatostatin release can be stimulated by carbachol 
(2). We had speculated previously that this effect might be mediated by the 
various intracellular signal transduction events triggered by the pertussis 
toxin insensitive turnover of membrane phosphoinositides induced by carbachol 
in D-cells. Furthermore, in the presence of pertussis toxin carbachol 
potentiated D-cell stimulation by forskolin, an agent known to activate 
adenylate cyclase directly. However, we noted in the present studies that 
carbachol was also able to potentiate the stimulation of somatostatin 
secretion induced by pentagastrin which, as noted above, acts via protein 
kinase C. Furthermore, the potentiating effect of carbachol was not 
accompanied by a further increment in cytosolic 3H-IP 3 content. These data 
lead us to conclude that the stimulatory effects of carbachol on D-cells may 
involve additional mechanisms beyond those dependent on membrane 
phosphoinositide turnover. 
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